Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
| Brand name | REVITADERM WOUND CARE |
| Generic name | BENZALKONIUM CHLORIDE |
| Active ingredient(s) | BENZALKONIUM CHLORIDE |
| Distributed by / for | Blaine Labs Inc |
| NDC | 63347-120-02 |
| Full product label | Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670, |
| Recalling firm | Blaine Labs Inc |
| Distribution | Nationwide in the USA |
| Quantity | 5,555 bottles and tubes |
| Recall initiated | 2026-04-08 |
| Report date | 2026-07-08 |
| Recall completed | — |
| Recall number | D-0699-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Santa Fe Springs CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗